Pharmacologic management of postoperative nausea and vomiting

Bibliography

• Lagasse R. Anesthesia Safety: model or myth?: a review of the published literature and analysis of current original data. Anesthesiology 2002;97:1609
   PubMed Web of Science ®Google Scholar
• Cooper J, Gaba D. No myth: anesthesia is a model for addressing patient safety. Anesthesiology 2002;97:1335
   PubMed Web of Science ®Google Scholar
• Apfel CC, Laara E, Koivuranta M, A simplified risk score for predicting postoperative nausea and vomiting: conclusions from cross-validations between two centers. Anesthesiology 1999;91:693-700
   PubMed Web of Science ®Google Scholar
• Koivuranta M, Laara E, Snare L, A survey of postoperative nausea and vomiting. Anaesthesia 1997;52:443-9
   PubMed Web of Science ®Google Scholar
• Sinclair DR, Chung F, Mezei G. Can postoperative nausea and vomiting be predicted? Anesthesiology 1999;91:109-18
   PubMed Web of Science ®Google Scholar
• Diemunsch P, Joshi GP, Brichant JF. Neurokinin-1 receptor antagonists in the prevention of postoperative nausea and vomiting. Br J Anaesth 2009;103:7-13
   PubMed Web of Science ®Google Scholar
• Kovac AL, Eberhart L, Kotarski J, A randomized, double-blind study to evaluate the efficacy and safety of three different doses of palonosetron versus placebo in preventing postoperative nausea and vomiting over a 72-hour period. Anesth Analg 2008;107:439-44
   PubMed Web of Science ®Google Scholar
• Macario A, Weinger M, Carney S, Which clinical anesthesia outcomes are important to avoid? The perspective of patients. Anesth Analg 1999;89:652-8
   PubMed Web of Science ®Google Scholar
• Darkow T, Gora-Harper ML, Goulson DT, Impact of antiemetic selection on postoperative nausea and vomiting and patient satisfaction. Pharmacotherapy 2001;21:540-8
   PubMed Web of Science ®Google Scholar
• van den Bosch JE, Bonsel GJ, Moons KG, Effect of postoperative experiences on willingness to pay to avoid postoperative pain, nausea, and vomiting. Anesthesiology 2006;104:1033-9
   PubMed Web of Science ®Google Scholar
• Zhang GS, Mathura JR Jr. Painless loss of vision after vomiting. N Engl J Med 2005;352:e16
   Web of Science ®Google Scholar
• Bremner WG, Kumar CM. Delayed surgical emphysema, pneumomediastinum and bilateral pneumothoraces after postoperative vomiting. Br J Anaesth 1993;71:296-7
   PubMed Web of Science ®Google Scholar
• Toprak V, Keles GT, Kaygisiz Z, Subcutaneous emphysema following severe vomiting after emerging from general anesthesia. Acta Anaesthesiol Scand 2004;48:917-18
   PubMed Web of Science ®Google Scholar
• Schumann R, Polaner DM. Massive subcutaneous emphysema and sudden airway compromise after postoperative vomiting. Anesth Analg 1999;89:796-7
   PubMed Web of Science ®Google Scholar
• Ero lu A, Kurkcuo lu C, Karao lano lu N, Spontaneous esophageal rupture following severe vomiting in pregnancy. Dis Esophagus 2002;15:242-3
   PubMed Web of Science ®Google Scholar
• Williams KS. Postoperative nausea and vomiting. Surg Clin North Am 2005;85:1229-41. xi
   PubMed Web of Science ®Google Scholar
• Dornhoffer J, Manning L. Unplanned admissions following outpatient otologic surgery: the University of Arkansas experience. Ear Nose Throat J 2000;79:710, 13-10, 17
   PubMedGoogle Scholar
• Gold BS, Kitz DS, Lecky JH, Unanticipated admission to the hospital following ambulatory surgery. JAMA 1989;262:3008-10
   PubMed Web of Science ®Google Scholar
• Hornby PJ. Central neurocircuitry associated with emesis. Am J Med 2001;111:106S-12S
   PubMed Web of Science ®Google Scholar
• Wang SC, Borison HL. The vomiting center; a critical experimental analysis. Arch Neurol Psychiatry 1950;63:928-41
   PubMedGoogle Scholar
• Miller AD, Leslie RA. The area postrema and vomiting. Front Neuroendocrinol 1994;15:301-20
   PubMed Web of Science ®Google Scholar
• Borison HL. Area postrema: chemoreceptor circumventricular organ. Prog Neurobiol 1989;32:351-90
   PubMed Web of Science ®Google Scholar
• Leslie RA. Neuroactive substances in the dorsal vagal complex of the medulla oblongata: nucleus of the tractus solitarius, area postrema, and dorsal motor nucleus of the vagus. Neurochem Int 1985;7:191-211
   PubMed Web of Science ®Google Scholar
• Golding JF, Gresty MA. Motion sickness. Curr Opin Neurol 2005;18:29-34
   PubMed Web of Science ®Google Scholar
• Shupak A, Gordon CR. Motion sickness: advances in pathogenesis, prediction, prevention, and treatment. Aviat Space Environ Med 2006;77:1213-23
   PubMed Web of Science ®Google Scholar
• Sherman C. Motion sickness: review of causes and preventive strategies. J Travel Med 2002;9:251-6
   PubMed Web of Science ®Google Scholar
• Eberhart LHJ, Hogel J, Seeling W, Evaluation of three risk scores to predict postoperative nausea and vomiting. Acta Anaesthesiol Scand 2000;44:480-8
   PubMed Web of Science ®Google Scholar
• Apfel CC, Bacher A, Biedler A, A factorial trial of six interventions for the prevention of postoperative nausea and vomiting. Results of the International Multicenter Protocol to assess the single and combined benefits of antiemetic strategies in a controlled clinical trial of a 2x2x2x2x2x2 factorial design (IMPACT). Anaesthesist 2005;54:201-9
   PubMed Web of Science ®Google Scholar
• Carpenter RL, Caplan RA, Brown DL, Incidence and risk factors for side effects of spinal anesthesia. Anesthesiology 1992;76:906-16
   PubMed Web of Science ®Google Scholar
• Koivuranta M, Laara E. A survey of postoperative nausea and vomiting. Anaesthesia 1998;53:413-14
   PubMed Web of Science ®Google Scholar
• Palazzo M, Evans R. Logistic regression analysis of fixed patient factors for postoperative sickness: a model for risk assessment. Br J Anaesth 1993;70:135-40
   PubMed Web of Science ®Google Scholar
• Apfel CC, Korttila K, Abdalla M, A factorial trial of six interventions for the prevention of postoperative nausea and vomiting. N Engl J Med 2004;350:2441-51
   PubMed Web of Science ®Google Scholar
• Cohen MM, Duncan PG, DeBoer DP, The postoperative interview: assessing risk factors for nausea and vomiting. Anesth Analg 1994;78:7-16
   PubMed Web of Science ®Google Scholar
• Apfel CC, Kranke P, Eberhart LHJ, A comparison of predicting models for postoperative nausea and vomiting. Br J Anaesth 2002;88:234-40
   PubMed Web of Science ®Google Scholar
• Pierre S, Benais H, Pouymayou J. Apfel's simplified score may favourably predict the risk of postoperative nausea and vomiting. Can J Anaesth 2002;49:237-42
   PubMed Web of Science ®Google Scholar
• Stadler M, Bardiau F, Seidel L, Difference in risk factors for postoperative nausea and vomiting. Anesthesiology 2003;98:46-52
   PubMed Web of Science ®Google Scholar
• van den Bosch JE, Kalkman CJ, Vergouwe Y, Assessing the applicability of scoring systems for predicting postoperative nausea and vomiting. Anaesthesia 2005;60:323-31
   PubMed Web of Science ®Google Scholar
• Eberhart LH, Geldner G, Kranke P, The development and validation of a risk score to predict the probability of postoperative vomiting in pediatric patients. Anesth Analg 2004;99:1630-7
   PubMed Web of Science ®Google Scholar
• Apfel CC, Greim CA, Goepfert C, Postoperative vomiting. A score for its prediction after inhalational anaesthesia. Anaesthesist 1998;47:732-40
   PubMed Web of Science ®Google Scholar
• Apfel CC, Greim CA, Haubitz I, A risk score to predict the probability of postoperative vomiting in adults. Acta Anaesthesiol Scand 1998;42:495-501
   PubMed Web of Science ®Google Scholar
• Apfel CC, Greim CA, Haubitz I, The discriminating power of a risk score for postoperative vomiting in adults undergoing various types of surgery. Acta Anaesthesiol Scand 1998;42:502-9
   PubMed Web of Science ®Google Scholar
• van den Bosch JE, Moons KG, Bonsel GJ, Does measurement of preoperative anxiety have added value for predicting postoperative nausea and vomiting? Anesth Analg 2005;100:1525-32
   PubMed Web of Science ®Google Scholar
• Friedberg BL. Propofol-ketamine technique: dissociative anesthesia for office surgery (a 5-year review of 1264 cases). Aesthetic Plast Surg 1999;23:70-5
   PubMed Web of Science ®Google Scholar
• Liu SS, Strodtbeck WM, Richman JM, A comparison of regional versus general anesthesia for ambulatory anesthesia: a meta-analysis of randomized controlled trials. Anesth Analg 2005;101:1634-42
   PubMed Web of Science ®Google Scholar
• Apfel CC, Kranke P, Katz MH, Volatile anaesthetics may be the main cause of early but not delayed postoperative vomiting: a randomized controlled trial of factorial design. Br J Anaesth 2002;88:659-68
   PubMed Web of Science ®Google Scholar
• Roberts GW, Bekker TB, Carlsen HH, Postoperative nausea and vomiting are strongly influenced by postoperative opioid use in a dose-related manner. Anesth Analg 2005;101:1343-8
   PubMed Web of Science ®Google Scholar
• Carlisle J, Stevenson C. Drugs for preventing postoperative nausea and vomiting. Cochrane Database Syst Rev 2006;3:CD004125
   Google Scholar
• Kovac AL. Prevention and treatment of postoperative nausea and vomiting. Drugs 2000;59:213-43
   PubMed Web of Science ®Google Scholar
• Fortney JT, Gan TJ, Graczyk S, A comparison of the efficacy, safety, and patient satisfaction of ondansetron versus droperidol as antiemetics for elective outpatient surgical procedures. S3A-409 and S3A-410 Study Groups. Anesth Analg 1998;86:731-8
   PubMed Web of Science ®Google Scholar
• Gralla RJ, Itri LM, Pisko SE, Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting. N Engl J Med 1981;305:905-9
   PubMed Web of Science ®Google Scholar
• Henzi I, Walder B, Tramer MR. Metoclopramide in the prevention of postoperative nausea and vomiting: a quantitative systematic review of randomized, placebo-controlled studies. Br J Anaesth 1999;83:761-71
   PubMed Web of Science ®Google Scholar
• Wallenborn J, Gelbrich G, Bulst D, Prevention of postoperative nausea and vomiting by metoclopramide combined with dexamethasone: randomised double blind multicentre trial. BMJ 2006;333:324-8
   PubMed Web of Science ®Google Scholar
• Eberhart LH, Morin AM, Seeling W, Meta-analysis of controlled randomized studies on droperidol for prevention of postoperative phase vomiting and nausea. Anasthesiol Intensivmed Notfallmed Schmerzther 1999;34:528-36
   PubMed Web of Science ®Google Scholar
• Henzi I, Sonderegger J, Tramer MR. Efficacy, dose-response, and adverse effects of droperidol for prevention of postoperative nausea and vomiting. Can J Anaesth 2000;47:537-51
   PubMed Web of Science ®Google Scholar
• Apfel CC, Cakmakkaya OS, Frings G, Droperidol has comparable clinical efficacy against both nausea and vomiting. Br J Anaesth 2009;103:359-63
   PubMed Web of Science ®Google Scholar
• White PF. Droperidol: a cost-effective antiemetic for over thirty years. Anesth Analg 2002;95:789-90
   PubMed Web of Science ®Google Scholar
• Dershwitz M. Droperidol: should the black box be light gray? J Clin Anesth 2002;14:598-603
   PubMed Web of Science ®Google Scholar
• Habib AS, Gan TJ. The use of droperidol before and after the Food and Drug Administration black box warning: a survey of the members of the Society of Ambulatory Anesthesia. J Clin Anesth 2008;20:35-9
   PubMed Web of Science ®Google Scholar
• Aouad MT, Siddik-Sayyid SM, Taha SK, Haloperidol vs. ondansetron for the prevention of postoperative nausea and vomiting following gynaecological surgery. Eur J Anaesthesiol 2007;24:171-8
   PubMed Web of Science ®Google Scholar
• Lee Y, Wang PK, Lai HY, Haloperidol is as effective as ondansetron for preventing postoperative nausea and vomiting. Can J Anaesth 2007;54:349-54
   PubMed Web of Science ®Google Scholar
• Napolitano C, Schwartz PJ, Brown AM, Evidence for a cardiac ion channel mutation underlying drug induced QT prolongation and life threatening arrhythmias. J Cardiovasc Electrophysiol 2000;11:691-6
   PubMed Web of Science ®Google Scholar
• Scuderi PE. Pharmacology of antiemetics. Int Anesthesiol Clin 2003;41:41
   PubMedGoogle Scholar
• Kranke P, Morin AM, Roewer N, Dimenhydrinate for prophylaxis of postoperative nausea and vomiting: a meta-analysis of randomized controlled trials. Acta Anaesthesiol Scand 2002;46:238-44
   PubMed Web of Science ®Google Scholar
• McCarthy B, Peroutka S. Differentiation of muscarinic cholinergic receptor subtypes in human cortex and pons: implications for anti-motion sickness therapy. Aviat Space Environ Med 1988;59:63
   PubMedGoogle Scholar
• Spinks A, Wasiak J, Bernath V, Scopolamine (hyoscine) for preventing and treating motion sickness (Review). Cochrane database of systematic reviews. 2007;3: CD002851
   Google Scholar
• Apfel CC, Zhang K, George E, Transdermal scopolamine for the prevention of postoperative nausea and vomiting: a systematic review and meta-analysis. Clin Ther 2010;32:1987-2002
   PubMed Web of Science ®Google Scholar
• Gilman AG, Goodman K, Gilman A. The pharmacological basis of therapeutics. Macmillan Publishing Co; 1980
   Google Scholar
• Kranke P, Morin AM, Roewer N, The efficacy and safety of transdermal scopolamine for the prevention of postoperative nausea and vomiting: a quantitative systematic review. Anesth Analg 2002;95:133-43
   PubMed Web of Science ®Google Scholar
• Sah N, Ramesh V, Kaul B, Transdermal scopolamine patch in addition to ondansetron for postoperative nausea and vomiting prophylaxis in patients undergoing ambulatory cosmetic surgery. J Clin Anesth 2009;21:249-52
   PubMed Web of Science ®Google Scholar
• Gan TJ, Sinha AC, Kovac AL, A randomized, double-blind, multicenter trial comparing transdermal scopolamine plus ondansetron to ondansetron alone for the prevention of postoperative nausea and vomiting in the outpatient setting. Anesth Analg 2009;108:1498-504
   PubMed Web of Science ®Google Scholar
• Lee HK, Lee JH, Chon SS, The effect of transdermal scopolamine plus intravenous dexamethasone for the prevention of postoperative nausea and vomiting in patients with epidural PCA after major orthopedic surgery. Korean J Anesthesiol 2010;58:50-5
   PubMedGoogle Scholar
• Goldstein D, Levi J, Woods R, Double-blind randomized cross-over trial of dexamethasone and prochlorperazine as anti-emetics for cancer chemotherapy. Oncology 1989;46:105-8
   PubMed Web of Science ®Google Scholar
• Ho CM, Ho ST, Wang JJ, Dexamethasone has a central antiemetic mechanism in decerebrated cats. Anesth Analg 2004;99:734-9, table
   PubMed Web of Science ®Google Scholar
• Henzi I, Walder B, Tramer MR. Dexamethasone for the prevention of postoperative nausea and vomiting: a quantitative systematic review. Anesth Analg 2000;90:186-94
   PubMed Web of Science ®Google Scholar
• Liu K, Hsu CC, Chia YY. The effect of dose of dexamethasone for antiemesis after major gynecological surgery. Anesth Analg 1999;89:1316-18
   PubMed Web of Science ®Google Scholar
• Wang JJ, Ho ST, Lee SC, The use of dexamethasone for preventing postoperative nausea and vomiting in females undergoing thyroidectomy: a dose-ranging study. Anesth Analg 2000;91:1404-7
   PubMed Web of Science ®Google Scholar
• Wang JJ, Ho ST, Wong CS, Dexamethasone prophylaxis of nausea and vomiting after epidural morphine for post-Cesarean analgesia. Can J Anaesth 2001;48:185-90
   PubMed Web of Science ®Google Scholar
• Gan TJ, Meyer TA, Apfel CC, Society for Ambulatory Anesthesia guidelines for the management of postoperative nausea and vomiting. Anesth Analg 2007;105:1615-28
   PubMed Web of Science ®Google Scholar
• Wang JJ, Ho ST, Tzeng JI, The effect of timing of dexamethasone administration on its efficacy as a prophylactic antiemetic for postoperative nausea and vomiting. Anesth Analg 2000;91:136-9
   PubMed Web of Science ®Google Scholar
• Gyermek L. 5-HT3 receptors: pharmacologic and therapeutic aspects. J Clin Pharmacol 1995;35:845-55
   PubMed Web of Science ®Google Scholar
• Loewen PS, Marra CA, Zed PJ. 5-HT3 receptor antagonists vs traditional agents for the prophylaxis of postoperative nausea and vomiting. Can J Anaesth 2000;47:1008-18
   PubMed Web of Science ®Google Scholar
• Russell D, Kenny GN. 5-HT3 antagonists in postoperative nausea and vomiting. Br J Anaesth 1992;69:63S-8S
   Web of Science ®Google Scholar
• Watcha MF, White PF. Postoperative nausea and vomiting. Its etiology, treatment, and prevention. Anesthesiology 1992;77:162-84
   PubMed Web of Science ®Google Scholar
• Hoyer D, Hannon JP, Martin GR. Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav 2002;71:533-54
   PubMed Web of Science ®Google Scholar
• Cubeddu LX, Hoffmann IS, Fuenmayor NT, Efficacy of ondansetron (GR 38032F) and the role of serotonin in cisplatin-induced nausea and vomiting. N Engl J Med 1990;322:810-16
   PubMed Web of Science ®Google Scholar
• Hesketh PJ, Gandara DR. Serotonin antagonists: a new class of antiemetic agents. J Natl Cancer Inst 1991;83:613
   PubMed Web of Science ®Google Scholar
• Goodin S, Cunningham R. 5-HT3-receptor antagonists for the treatment of nausea and vomiting: a reappraisal of their side-effect profile. Oncologist 2002;7:424
   PubMed Web of Science ®Google Scholar
• Benedict CR, Arbogast R, Martin L, Single-blind study of the effects of intravenous dolasetron mesylate versus ondansetron on electrocardiographic parameters in normal volunteers. J Cardiovasc Pharmacol 1996;28:53-9
   PubMed Web of Science ®Google Scholar
• Boike SC, Ilson B, Zariffa N, Cardiovascular effects of i.v. granisetron at two administration rates and of ondansetron in healthy adults. Am J Health Syst Pharm 1997;54:1172-6
   PubMed Web of Science ®Google Scholar
• Therapeutics ACfEaRo. QT drug list. Available from: http://wwwazcertorg/medical-pros/drug-lists/list-02cfm?sort=Generic_name
   Google Scholar
• Baguley WA, Hay WT, Mackie KP, Cardiac dysrhythmias associated with the intravenous administration of ondansetron and metoclopramide. Anesth Analg 1997;84:1380-1
   PubMed Web of Science ®Google Scholar
• Kasinath NS, Malak O, Tetzlaff J. Atrial fibrillation after ondansetron for the prevention and treatment of postoperative nausea and vomiting: a case report. Can J Anaesth 2003;50:229-31
   PubMed Web of Science ®Google Scholar
• Charbit B, Albaladejo P, Funck-Brentano C, Prolongation of QTc interval after postoperative nausea and vomiting treatment by droperidol or ondansetron. Anesthesiology 2005;102:1094-100
   PubMed Web of Science ®Google Scholar
• Helsinn Healthcare SEI. Aloxi Full Prescribing Information; 2008
   Google Scholar
• Gralla R, Lichinitser M, Van Der Vegt S, Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetron. Ann Oncol 2003;14:1570-7
   PubMed Web of Science ®Google Scholar
• Rojas C, Stathis M, Thomas AG, Palonosetron exhibits unique molecular interactions with the 5-HT3 receptor. Anesth Analg 2008;107:469-78
   PubMed Web of Science ®Google Scholar
• Nielsen M, Olsen NV. Genetic polymorphisms in the cytochrome P450 system and efficacy of 5-hydroxytryptamine type 3 receptor antagonists for postoperative nausea and vomiting. Br J Anaesth 2008;101:441-5
   PubMed Web of Science ®Google Scholar
• Touw D. Clinical implications of genetic polymorphisms and drug interactions mediated by cytochrome P-450 enzymes. Drug Metabol Drug Interact 1997;14:55
   PubMedGoogle Scholar
• Fischer V, Vickers AE, Heitz F, The polymorphic cytochrome P-4502D6 is involved in the metabolism of both 5-hydroxytryptamine antagonists, tropisetron and ondansetron. Drug Metab Dispos 1994;22:269-74
   PubMed Web of Science ®Google Scholar
• Sanwald P, David M, Dow J. Characterization of the cytochrome P450 enzymes involved in the in vitro metabolism of dolasetron. Comparison with other indole-containing 5-HT3 antagonists. Drug Metab Dispos 1996;24:602
   PubMed Web of Science ®Google Scholar
• Kaiser R, Sezer O, Papies A, Patient-tailored antiemetic treatment with 5-hydroxytryptamine type 3 receptor antagonists according to cytochrome P-450 2D6 genotypes. J Clin Oncol 2002;20:2805-11
   PubMed Web of Science ®Google Scholar
• Candiotti KA, Birnbach DJ, Lubarsky DA, The impact of pharmacogenomics on postoperative nausea and vomiting: do CYP2D6 allele copy number and polymorphisms affect the success or failure of ondansetron prophylaxis? Anesthesiology 2005;102:543-9
   PubMed Web of Science ®Google Scholar
• Amin AH, Crawford TB, Gaddum JH. The distribution of substance P and. 5-hydroxytryptamine in the central nervous system of the dog. J Physiol 1954;126:596-618
   PubMed Web of Science ®Google Scholar
• Gan TJ. Mechanisms underlying postoperative nausea and vomiting and neurotransmitter receptor antagonist-based pharmacotherapy. CNS Drugs 2007;21:813-33
   PubMed Web of Science ®Google Scholar
• Saito R, Takano Y, Kamiya H. Roles of Substance P and NK1 receptor in the brainstem in the development of emesis. J Pharmacol Sci 2003;91:87-94
   PubMed Web of Science ®Google Scholar
• Tattersall FD, Rycroft W, Francis B, Tachykinin NK1 receptor antagonists act centrally to inhibit emesis induced by the chemotherapeutic agent cisplatin in ferrets. Neuropharmacology 1996;35:1121-9
   PubMed Web of Science ®Google Scholar
• Diemunsch P, Schoeffler P, Bryssine B, Antiemetic activity of the NK1 receptor antagonist GR205171 in the treatment of established postoperative nausea and vomiting after major gynaecological surgery. Br J Anaesth 1999;82:274-6
   PubMed Web of Science ®Google Scholar
• Gesztesi Z, Scuderi PE, White PF, Substance P (Neurokinin-1) antagonist prevents postoperative vomiting after abdominal hysterectomy procedures. Anesthesiology 2000;93:931-7
   PubMed Web of Science ®Google Scholar
• Diemunsch P, Gan TJ, Philip BK, Single-dose aprepitant vs ondansetron for the prevention of postoperative nausea and vomiting: a randomized, double-blind phase III trial in patients undergoing open abdominal surgery. Br J Anaesth 2007;99:202-11
   PubMed Web of Science ®Google Scholar
• Gan TJ, Apfel CC, Kovac A, A randomized, double-blind comparison of the NK1 antagonist, aprepitant, versus ondansetron for the prevention of postoperative nausea and vomiting. Anesth Analg 2007;104:1082-9
   PubMed Web of Science ®Google Scholar
• Diemunsch P, Apfel C, Gan TJ, Preventing postoperative nausea and vomiting: post hoc analysis of pooled data from two randomized active-controlled trials of aprepitant. Curr Med Res Opin 2007;23:2559-65
   PubMed Web of Science ®Google Scholar
• Gan TJ, Gu J, Singla N, Rolapitant for the prevention of postoperative nausea and vomiting: a prospective, double-blinded, placebo-controlled randomized trial. Anesth Analg 2011;112:804-12
   PubMed Web of Science ®Google Scholar
• Singla NK, Singla SK, Chung F, Phase II study to evaluate the safety and efficacy of the oral neurokinin-1 receptor antagonist casopitant (GW679769) administered with ondansetron for the prevention of postoperative and postdischarge nausea and vomiting in high-risk patients. Anesthesiology 2010;113:74-82
   PubMed Web of Science ®Google Scholar
• Shadle CR, Lee Y, Majumdar AK, Evaluation of potential inductive effects of aprepitant on cytochrome P450 3A4 and 2C9 activity. J Clin Pharmacol 2004;44:215
   PubMed Web of Science ®Google Scholar
• Depre M, Van Hecken A, Oeyen M, Effect of aprepitant on the pharmacokinetics and pharmacodynamics of warfarin. Eur J Clin Pharmacol 2005;61:341-6
   PubMed Web of Science ®Google Scholar
• Nimmo W. Effect of anaesthesia on gastric motility and emptying. Br J Anaesth 1984;56:29
   PubMed Web of Science ®Google Scholar
• Nimmo W, Heading R, Wilson J, Inhibition of gastric emptying and drug absorption by narcotic analgesics. Br J Clin Pharmacol 1975;2:509
   PubMed Web of Science ®Google Scholar
• Todd J, Nimmo W. Effect of premedication on drug absorption and gastric emptying. Br J Anaesth 1983;55:1189
   PubMed Web of Science ®Google Scholar
• Gan TJ, Ginsberg B, Glass PS, Opioid-sparing effects of a low-dose infusion of naloxone in patient-administered morphine sulfate. Anesthesiology 1997;87:1075-81
   PubMed Web of Science ®Google Scholar
• Murphy D, Sutton J, Prescott L, Opioid-induced delay in gastric emptying: a peripheral mechanism in humans. Anesthesiology 1997;87:765
   PubMed Web of Science ®Google Scholar
• Foss JF, Bass AS, Goldberg LI. Dose-related antagonism of the emetic effect of morphine by methylnaltrexone in dogs. J Clin Pharmacol 1993;33:747-51
   PubMed Web of Science ®Google Scholar
• Viscusi ER, Goldstein S, Witkowski T, Alvimopan, a peripherally acting mu-opioid receptor antagonist, compared with placebo in postoperative ileus after major abdominal surgery: results of a randomized, double-blind, controlled study. Surg Endosc 2006;20:64-70
   PubMed Web of Science ®Google Scholar
• Wolff BG, Michelassi F, Gerkin TM, Alvimopan, a novel, peripherally acting mu opioid antagonist: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial of major abdominal surgery and postoperative ileus. Ann Surg 2004;240:728-34
   PubMed Web of Science ®Google Scholar
• Apfel C, Foss J, Jalota L, Effect of Alvimopan on opioid-induced nausea [abstract A224]. American Society of Anesthesiologists; San Diego: 2010
   Google Scholar
• Tramer MR, Moore A, McQuay H. Omitting nitrous oxide in general anaesthesia: meta-analysis of intraoperative awareness and postoperative emesis in randomized controlled trials. Br J Anaesth 1996;76:186-93
   PubMed Web of Science ®Google Scholar
• Gupta A, Stierer T, Zuckerman R, Comparison of recovery profile after ambulatory anesthesia with propofol, isoflurane, sevoflurane and desflurane: a systematic review. Anesth Analg 2004;98:632-41, table
   PubMed Web of Science ®Google Scholar
• Visser K, Hassink EA, Bonsel GJ, Randomized controlled trial of total intravenous anesthesia with propofol versus inhalation anesthesia with isoflurane-nitrous oxide: postoperative nausea with vomiting and economic analysis. Anesthesiology 2001;95:616-26
   PubMed Web of Science ®Google Scholar
• Pierre S, Corno G, Benais H, A risk score-dependent antiemetic approach effectively reduces postoperative nausea and vomiting–a continuous quality improvement initiative. Can J Anaesth 2004;51:320-5
   PubMed Web of Science ®Google Scholar
• Scuderi PE, James RL, Harris L, Multimodal antiemetic management prevents early postoperative vomiting after outpatient laparoscopy. Anesth Analg 2000;91:1408-14
   PubMed Web of Science ®Google Scholar
• Habib AS, White WD, Eubanks S, A randomized comparison of a multimodal management strategy versus combination antiemetics for the prevention of postoperative nausea and vomiting. Anesth Analg 2004;99:77-81
   PubMed Web of Science ®Google Scholar
• Kovac AL, O'Connor TA, Pearman MH, Efficacy of repeat intravenous dosing of ondansetron in controlling postoperative nausea and vomiting: a randomized, double-blind, placebo- controlled multicenter trial. J Clin Anesth 1999;11:453-9
   PubMed Web of Science ®Google Scholar
• Biedler A, Wermelt J, Kunitz O, A risk adapted approach reduces the overall institutional incidence of postoperative nausea and vomiting. Can J Anaesth 2004;51:13-19
   PubMed Web of Science ®Google Scholar